Restorative Therapies, Inc., Receives FDA Clearance for Enhancement to RT300-S Electrical Stimulation Cycle

Restorative Therapies, Inc., a designer of medical devices providing clinic and in-home resoration therapy, today announced FDA clearance of wireless pulse oximetry for its successful medical device, the RT300-S, a Functional electrical stimulation (FES) motorized cycle ergometer.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
This is the latest result of our strong commitment to ongoing development of the RT300-S system as we work to deliver improved outcomes for our patients.

Baltimore, MD (PRWEB) July 10, 2007

Restorative Therapies, Inc., advances its New Era in Treatment for Neurological Injury and Paralysis.

Restorative Therapies, Inc., a designer of medical devices, today announced FDA clearance of a BlueTooth Pulse Oximeter for its successful medical device, the RT300-S, a functional electrical stimulation (FES) motorized cycle ergometer.

In the treatment of neurological damage, FES is used to evoke physical activity and exercise not otherwise possible for individuals with paralysis. The RT300-S delivers electrical currents to activate the leg muscles important for walking including the quadriceps, hamstring and gluteal muscles, enabling paralyzed legs to move through a regular patterned physical activity.

The new RT300-S Pulse Oximeter will allow individuals to monitor their pulse rate and spot oxygen saturation while using the RT300-S. The pulse oximetry data is also saved into the RT300-S internet database. This database allows both patients and clinicians are able to monitor therapy progress no matter where the patient lives.

"The RT300-S Pulse Oximeter interface will allow clinicians to optimize the physical benefits of exercise in individual patients by applying heart rate range response in producing optimal cardiovascular conditioning, both when the patient is in the clinic and when at home," says John McDonald, MD, PhD, founder of Restorative Therapies, Inc., lead Neurologist to the Late Christopher Reeve, and director of the International Center for Spinal Cord Injury at the Kennedy Krieger Institute in Baltimore. "This will add to the outcome data that is already being collected from so many RT300-S patients - making it an even more valuable research tool," McDonald concludes.

"The BlueTooth Pulse Oximeter will help clinicians see how hard patients are working and progressing in their electrical stimulation therapy," says Andrew Barriskill, CEO of Restorative Therapies. "This is the latest result of our strong commitment to ongoing development of the RT300-S system as we work to deliver improved outcomes for our patients."

About Restorative Therapies, Inc.
Restorative Therapies, is a privately-held company headquartered in Baltimore, Md., whose mission is to help people with neurological impairment achieve their full recovery potential. Restorative Therapies is one of the first companies to target activity-based therapy and FES as a treatment for immobility associated with paralysis such as stroke, multiple sclerosis and spinal cord injury.
For further information please call 800 609-9166.

About Dr. John McDonald
John W. McDonald, MD, PhD, directs the International Center for Spinal Cord Injury at Kennedy Krieger Institute. From 1998-2004, prior to joining Kennedy Krieger, he founded and served as director of the Spinal Cord Injury Program at Washington University School of Medicine in St. Louis. His clinical and scientific work has been recognized by many organizations, including the National Institutes of Health, International Neurotrauma Society and American Academy of Neurology.

###


Contact

Attachments